- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
New Campaign Seeks to Curb Unnecessary Healthcare Services
With the cost of medically unnecessary care estimated to be in the billions of dollars, a new campaign is setting out to change the medical profession’s and society’s usage of healthcare.
Choosing Wisely, a campaign developed by the American Board of Internal Medicine (ABIM) Foundation in partnership with Consumer Reports and 9 medical societies, seeks to get patients and doctors and others in the medical profession to think and talk about overuse or misuse of healthcare resources.
During the multi-year campaign, each specialty society will target 5 common tests or procedures that each designates needs discussion or should be questioned. The parameters used to narrow the options include limiting the 5 to the specialty’s purview and control; frequency and/or cost of the procedures; and having evidence supporting each recommended target. The societies will announce their self-developed lists in April of next year.
Read more at: http://tinyurl.com/7ocofh5
Source: Healthcare Finance News
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Reviving the Classics: The Role of Older Medications in Modern Dermatology
March 9th 2025Older, generic medications, including ones for cyclosporine, nicotinamide, and dapsone, can effectively treat patients with various dermatological conditions while helping to reduce insurance and cost barriers.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
